603392 萬泰生物
按盤價 
72.480 -5.880 (-7.504%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.431 | 0.851 | 9.965 | 56.353 | 57.592 |
| 總資產報酬率 ROA (%) | -0.362 | 0.699 | 7.812 | 40.693 | 38.323 |
| 投入資產回報率 ROIC (%) | -0.416 | 0.821 | 9.626 | 53.875 | 53.908 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.551 | 66.196 | 84.154 | 89.536 | 85.780 |
| 營業利潤率 (%) | -13.927 | 4.179 | 25.431 | 50.031 | 40.493 |
| 息稅前利潤/營業總收入 (%) | -16.012 | 0.419 | 23.598 | 49.361 | 40.508 |
| 淨利潤/營業總收入 (%) | -13.514 | 4.859 | 22.619 | 43.480 | 36.158 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 111.131 | -222.609 | 117.129 | 97.395 | 100.950 |
| 價值變動淨收益/利潤總額(%) | -53.255 | 216.867 | 8.867 | 0.826 | 0.484 |
| 營業外收支淨額/利潤總額(%) | 3.633 | -39.058 | -0.578 | -0.239 | -0.185 | 償債能力分析 |
| 流動比率 (X) | 4.137 | 4.162 | 3.858 | 3.495 | 1.964 |
| 速動比率 (X) | 3.615 | 3.733 | 3.519 | 3.245 | 1.713 |
| 資產負債率 (%) | 14.347 | 15.259 | 18.017 | 22.580 | 35.247 |
| 帶息債務/全部投入資本 (%) | 2.267 | 2.518 | 3.215 | 2.628 | 5.144 |
| 股東權益/帶息債務 (%) | 4,262.828 | 3,828.624 | 2,999.358 | 3,682.842 | 1,798.492 |
| 股東權益/負債合計 (%) | 588.146 | 547.096 | 448.572 | 336.767 | 179.842 |
| 利息保障倍數 (X) | 10.266 | -0.162 | -13.986 | -89.610 | 448.350 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 440.949 | 403.347 | 226.370 | 99.701 | 92.256 |
| 存貨周轉天數 (天) | 612.847 | 419.425 | 365.800 | 224.891 | 218.631 |
| 備註： | 即時報價更新時間為 06/06/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
